MDB Capital Holdings, LLC functions primarily as a broker-dealer through its subsidiary operations. The company's activities are divided into two main areas: Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service division provides comprehensive broker-dealer services, focusing on arranging private and public securities offerings, and furnishing research for investment banking due diligence. Meanwhile, the Technology Development division is engaged in the advancement of synthetic biology technology. MDB Capital Holdings, LLC was established in 1997 and is based in Addison, Texas.
MDB Capital Holdings Provides Second Quarter 2026 Update
MDB Capital reported strong operational momentum in the first half of 2026, completing its 18th consecutive successful IPO with the $20 million Buda Juice listing and participating in the Ticketplus and eXoZymes offerings.
Financially, the firm recorded a net loss of $16.1 million, largely driven by $10 million in non-cash items related to stock-based compensation and investment security valuations, while fixed operating expenses remained flat at approximately $5 million.
Strategic initiatives include advancing the spin-out of PatentVest and upgrading the MDB Direct platform to BetaNXT to enhance security and capabilities for investors.